Neko Health: Transforming Healthcare with AI-Driven Preventive Scans
Stockholm, Monday, 31 March 2025.
Neko Health, co-founded by Daniel Ek, innovates in preventive care with AI scans. The company, valued at $1.8 billion, has a 100,000-person waitlist and plans global expansion.
Revolutionary Scanning Technology
Neko Health’s innovative full-body scanning system employs over 70 sensors to collect 50 million data points in just 10 minutes, providing comprehensive measurements of heart function, circulation, and skin conditions [1]. The technology’s effectiveness is evidenced by their 2023 data, which revealed that among 2,707 scanned individuals, 14.1% required medical treatment, and 1% received potentially life-saving interventions for previously undetected conditions [1].
Rapid Market Expansion
Following its successful launch in Stockholm in 2023, Neko Health expanded to London in 2024, where it established its clinic in Marylebone [2]. The company’s growth trajectory continues with plans for a second London location in the east, driven by extraordinary demand [2]. Currently operating with over 200 employees across Europe [5], Neko Health demonstrates its commitment to accessibility by pricing its comprehensive scans at £299 ($380), with discounted rates of £249 for subsequent annual appointments [2].
Investment and Future Prospects
The company’s recent Series B funding round secured $260 million, establishing a valuation of $1.8 billion [1]. As co-founder Hjalmar Nilsonne emphasizes, ‘Healthcare costs are spiraling out of control. We believe preventive health will be key to reversing this trend’ [1]. This vision aligns with broader healthcare industry trends, as evidenced by recent developments in AI-driven diagnostics and preventive care [6].
Impact on Healthcare Delivery
Neko Health’s approach represents a significant shift in healthcare delivery, moving from reactive to proactive care models [2]. The company’s success in detecting health issues early is particularly relevant given current healthcare challenges, including the decreasing number of clinical researchers in the UK [6] and growing pressure on traditional healthcare systems [alert! ‘long-term impact on healthcare systems yet to be fully evaluated’].